Cardio Diagnostics Holdings Inc
CDIO3.520USD
+0.160+4.76%
收盘 12/24, 13:00（美东）报价延迟15分钟
6.22M总市值
亏损市盈率 TTM
关于 Cardio Diagnostics Holdings Inc 公司
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Cardio Diagnostics Holdings Inc简介
公司代码CDIO
公司名称Cardio Diagnostics Holdings Inc
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)
员工数量13
证券类型Ordinary Share
年结日Nov 23
公司地址311 W. Superior Street
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编60645
电话18552269991
网址
公司代码CDIO
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)
Cardio Diagnostics Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
其他
89.74%
持股股东
持股股东
占比
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
其他
89.74%
股东类型
持股股东
占比
Investment Advisor
4.35%
Individual Investor
3.90%
Corporation
2.90%
Hedge Fund
1.12%
Investment Advisor/Hedge Fund
0.83%
其他
86.91%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
39
115.09K
6.22%
--
2025Q3
41
115.09K
6.70%
+30.25K
2025Q2
39
84.84K
5.90%
+274.00
2025Q1
35
84.57K
5.41%
-9.47K
2024Q4
39
85.72K
5.08%
+29.79K
2024Q3
59
55.93K
19.52%
-4.45K
2024Q2
61
60.37K
27.33%
+6.29K
2024Q1
58
54.08K
29.21%
-151.37K
2023Q4
58
55.21K
23.41%
+40.18K
2023Q3
53
15.03K
36.07%
+2.55K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Dogan (Meeshanthini)
55.18K
3.13%
--
--
Aug 25, 2025
Bd Holding, Inc
52.88K
3%
--
--
Aug 25, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
2.02%
-2.00
-0.01%
Jun 30, 2025
The Vanguard Group, Inc.
12.68K
0.72%
+265.00
+2.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
13.37K
0.76%
+198.00
+1.50%
Jun 30, 2025
Dogan (Timur)
4.28K
0.24%
--
--
Aug 25, 2025
Hosseinion (Warren)
3.87K
0.22%
+1.00
+0.03%
Aug 25, 2025
Philibert (Robert)
3.25K
0.18%
+1.00
+0.03%
Aug 25, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 08, 2025
Merger
30→1
公告日期
类型
比率
May 08, 2025
Merger
30→1
常见问题
Cardio Diagnostics Holdings Inc的前五大股东是谁？
Cardio Diagnostics Holdings Inc 的前五大股东如下：
Dogan (Meeshanthini)持有股份：55.18K，占总股份比例：3.13%。
Bd Holding, Inc持有股份：52.88K，占总股份比例：3.00%。
BlackRock Institutional Trust Company, N.A.持有股份：35.57K，占总股份比例：2.02%。
The Vanguard Group, Inc.持有股份：12.68K，占总股份比例：0.72%。
Geode Capital Management, L.L.C.持有股份：13.37K，占总股份比例：0.76%。
Dogan (Meeshanthini)持有股份：55.18K，占总股份比例：3.13%。
Bd Holding, Inc持有股份：52.88K，占总股份比例：3.00%。
BlackRock Institutional Trust Company, N.A.持有股份：35.57K，占总股份比例：2.02%。
The Vanguard Group, Inc.持有股份：12.68K，占总股份比例：0.72%。
Geode Capital Management, L.L.C.持有股份：13.37K，占总股份比例：0.76%。
Cardio Diagnostics Holdings Inc的前三大股东类型是什么？
Cardio Diagnostics Holdings Inc 的前三大股东类型分别是：
Dogan (Meeshanthini)
Bd Holding, Inc
BlackRock Institutional Trust Company, N.A.
Dogan (Meeshanthini)
Bd Holding, Inc
BlackRock Institutional Trust Company, N.A.
有多少机构持有Cardio Diagnostics Holdings Inc(CDIO)的股份？
截至2025Q4，共有39家机构持有Cardio Diagnostics Holdings Inc的股份，合计持有的股份价值约为115.09K，占公司总股份的6.22%。与2025Q3相比，机构持股有所增加，增幅为-0.48%。
哪个业务部门对Cardio Diagnostics Holdings Inc的收入贡献最大？
在--，--业务部门对Cardio Diagnostics Holdings Inc的收入贡献最大，创收--，占总收入的--%。
